• DOI:10.1021/jm9505066
Corpus ID: 6265819

Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret.

@article{Duplantier1996BiarylcarboxylicAA,
  title={Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret.},
  author={Allen J. Duplantier and Michael S. Biggers and Robert J. Chambers and John B. Cheng and Kevin L. Cooper and David B. Damon and James F. Eggler and Kenneth G. Kraus and Anthony Marfat and Hiroko Masamune and J. S. Pillar and J. T. Shirley and John P. Umland and John W. Watson},
  journal={Journal of medicinal chemistry},
  year={1996},
  volume={39 1},
  pages={
          120-5
        }
}

Allen J. Duplantier, Michael S. Biggers, +11 authors John W. Watson

Published in

Journal of medicinal…

1996

Chemistry, Medicine

In addition to having desirable inhibitory effects on inflammation, anaphylaxis, and smooth muscle contraction, PDE-IV inhibitors also produce undesirable side effects including nausea and vomiting. In general, compounds that inhibit PDE-IV also potently displace [3H]rolipram from a high-affinity binding site in rat cortex. While this binding site has not been identified, it has been proposed to be an allosteric binding site on the PDE-IV enzyme. Preliminary studies have suggested that the… CONTINUE READING

View on PubMed

Alternate Sources

Save to Library

Create Alert

Cite

Launch Research Feed

Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv